Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial source : Www.adnas.com save search
Manuscript Demonstrates that LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial
Published: 2022-09-30 (Crawled : 14:00) - adnas.com
APDN | $0.2418 -16.62% -19.93% 1.2M
|
Commercial Services
|
| O: -0.82%
H: 11.56%
C: -6.61%
candidate vaccine virus trial
Applied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets
Published: 2022-09-30 (Crawled : 13:20) - adnas.com
APDN | $0.2418 -16.62% -19.93% 1.2M
|
Commercial Services
|
| O: -0.82%
H: 11.56%
C: -6.61%
candidate vaccine virus trial
Veterinary COVID-19 Vaccine Candidate Induces Neutralizing Antibodies in 100% of Trial Cohort
Published: 2021-06-07 (Crawled : 14:15) - adnas.com
APDN | $0.2418 -16.62% -19.93% 1.2M
|
Commercial Services
|
| O: 3.45%
H: 4.67%
C: 4.5%
covid vaccine trial antibody covid-19
APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial
Published: 2021-04-12 (Crawled : 18:00) - adnas.com
APDN | $0.2418 -16.62% -19.93% 1.2M
|
Commercial Services
|
| O: -0.42%
H: 10.47%
C: -6.22%
positive results trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.